Cedars-Sinai Medical Center: Acromegaly trials
The registry lists 10 Acromegaly studies with Cedars-Sinai Medical Center as lead sponsor. 1 are open to participants now and 4 have results posted.
Phase 4 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Diet in the Management of AcromegalyRecruitingNCT05401084Not applicable
- Acromegaly Combination Treatment StudyTerminatedNCT01538966Not applicableResults posted
- Tissue Biomarker for Pegvisomant ActionCompletedNCT01261000Not applicableResults posted
- Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)CompletedNCT00915954Not applicableResults posted
- Ultrasound Guided Octreotide LAR Injection in AcromegalyCompletedNCT00552071Phase 4Results posted
- Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin AnalogsWithdrawnNCT01371045
- Peri-operative Dynamics of the Growth Hormone Axis in Subjects With AcromegalyCompletedNCT00921609
- Lanreotide Levels in AcromegalyStatus unknownNCT00916916
- Inter-Assay Growth Hormone and IGF-I VariabilityWithdrawnNCT00638287
- Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary AdenomaStatus unknownNCT00598949